Literature DB >> 31186855

Hepatitis C viral infection in drug users.

Diana L Sylvestre1.   

Abstract

Entities:  

Year:  2012        PMID： 31186855      PMCID： PMC6499272          DOI： 10.1002/cld.72

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  17 in total

1.  Immune response in addicts with chronic hepatitis C treated with interferon and ribavirin.

Authors:  Neri Sergio; Travali Salvatore; Bertino Gaetano; Pulvirenti Davide; Italiano Claudio; Libbra Massimo; Mauceri Barbara; Abate Giuseppe; Calvagno Stefano; Cilio Danila; Tsami Aikaterini; Ignaccolo Luca; Callari Daniela; Caruso Luciano
Journal:  J Gastroenterol Hepatol       Date:  2007-01       Impact factor: 4.029

Review 2.  Non-injection drug use and Hepatitis C Virus: a systematic review.

Authors:  Roberta Scheinmann; Holly Hagan; Corina Lelutiu-Weinberger; Rebecca Stern; Don C Des Jarlais; Peter L Flom; Shiela Strauss
Journal:  Drug Alcohol Depend       Date:  2006-12-15       Impact factor: 4.492

3.  Barriers to interferon-alpha therapy are higher in intravenous drug users than in other patients with acute hepatitis C.

Authors:  Barbara Broers; Beat Helbling; Anne François; Patrick Schmid; Christian Chuard; Antoine Hadengue; Francesco Negro
Journal:  J Hepatol       Date:  2005-03       Impact factor: 25.083

4.  Hepatitis C treatment candidacy and outcomes among 4318 US veterans with chronic hepatitis C virus infection: does a history of injection drug use matter?

Authors:  Karen H Seal; Sue L Currie; Hui Shen; Bhupinderjit S Anand; Edmund J Bini; Norbert Brau; Lennox Jeffers; Teresa L Wright
Journal:  J Clin Gastroenterol       Date:  2007-02       Impact factor: 3.062

5.  [Early treatment of acute hepatitis C with interferon alpha-2b or interferon alpha-2b plus ribavirin: study of sixteen patients].

Authors:  Pierre Rocca; François Bailly; Michèle Chevallier; Philippe Chevallier; Fabien Zoulim; Christian Trépo
Journal:  Gastroenterol Clin Biol       Date:  2003-03

6.  Treatment of chronic hepatitis C in injecting drug users: 5 years' follow-up.

Authors:  O Dalgard; K Bjøro; K Hellum; B Myrvang; K Skaug; B Gutigard; H Bell
Journal:  Eur Addict Res       Date:  2002-01       Impact factor: 3.015

7.  Acute hepatitis C virus infection in incarcerated injection drug users.

Authors:  Barbara H McGovern; Alysse Wurcel; Arthur Y Kim; Julian Schulze zur Wiesch; Ioana Bica; M Tauheed Zaman; Joerg Timm; Bruce D Walker; Georg M Lauer
Journal:  Clin Infect Dis       Date:  2006-05-11       Impact factor: 9.079

8.  A prospective controlled study of interferon-based therapy of chronic hepatitis C in patients on methadone maintenance.

Authors:  Stefan Mauss; Florian Berger; Joerg Goelz; Bernhard Jacob; Günther Schmutz
Journal:  Hepatology       Date:  2004-07       Impact factor: 17.425

9.  Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects.

Authors:  Martin Schaefer; Axel Hinzpeter; Ariane Mohmand; Gesa Janssen; Maurice Pich; Markus Schwaiger; Rahul Sarkar; Astrid Friebe; Andreas Heinz; Michael Kluschke; Marlene Ziemer; Juri Gutsche; Viola Weich; Juliane Halangk; Thomas Berg
Journal:  Hepatology       Date:  2007-10       Impact factor: 17.425

10.  Infrequent reinfection after successful treatment for hepatitis C virus infection in injection drug users.

Authors:  Markus Backmund; Kirsten Meyer; Brian R Edlin
Journal:  Clin Infect Dis       Date:  2004-10-26       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.